UBS Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.52M Buy
41,417
+2,244
+6% +$214K ﹤0.01% 4172
2025
Q4
$3.18M Buy
39,173
+15,447
+65% +$1.33M ﹤0.01% 4498
2025
Q3
$2.08M Buy
23,726
+4,599
+24% +$411K ﹤0.01% 4914
2025
Q2
$1.59M Sell
19,127
-6,876
-26% -$575K ﹤0.01% 5037
2025
Q1
$2.18M Buy
26,003
+2,791
+12% +$260K ﹤0.01% 4627
2024
Q4
$2.14M Buy
23,212
+16,982
+273% +$1.63M ﹤0.01% 4660
2024
Q3
$579K Sell
6,230
-2,560
-29% -$222K ﹤0.01% 5114
2024
Q2
$723K Sell
8,790
-11,455
-57% -$842K ﹤0.01% 4707
2024
Q1
$1.34M Sell
20,245
-746
-4% -$46K ﹤0.01% 4342
2023
Q4
$1.19M Buy
20,991
+8,351
+66% +$437K ﹤0.01% 4342
2023
Q3
$689K Sell
12,640
-8,208
-39% -$486K ﹤0.01% 4401
2023
Q2
$1.4M Buy
20,848
+4,422
+27% +$270K ﹤0.01% 3900
2023
Q1
$845K Buy
16,426
+7,693
+88% +$373K ﹤0.01% 4259
2022
Q4
$402K Buy
8,733
+4,930
+130% +$231K ﹤0.01% 4889
2022
Q3
$193K Buy
3,803
+3,012
+381% +$151K ﹤0.01% 5114
2022
Q2
$36K Sell
791
-3,870
-83% -$173K ﹤0.01% 6190
2022
Q1
$217K Sell
4,661
-2,034
-30% -$91K ﹤0.01% 5288
2021
Q4
$336K Buy
6,695
+5,771
+625% +$298K ﹤0.01% 5289
2021
Q3
$49K Sell
924
-2,166
-70% -$122K ﹤0.01% 6348
2021
Q2
$188K Sell
3,090
-6,440
-68% -$342K ﹤0.01% 5397
2021
Q1
$465K Sell
9,530
-4,445
-32% -$208K ﹤0.01% 4923
2020
Q4
$566K Buy
13,975
+7,841
+128% +$280K ﹤0.01% 4507
2020
Q3
$199K Sell
6,134
-3,787
-38% -$114K ﹤0.01% 4799
2020
Q2
$262K Sell
9,921
-2,271
-19% -$59.4K ﹤0.01% 4608
2020
Q1
$304K Sell
12,192
-7,079
-37% -$219K ﹤0.01% 4387
2019
Q4
$693K Buy
19,271
+5,531
+40% +$191K ﹤0.01% 4548
2019
Q3
$470K Buy
13,740
+10,549
+331% +$337K ﹤0.01% 4622
2019
Q2
$89K Buy
3,191
+1,955
+158% +$54.3K ﹤0.01% 5454
2019
Q1
$38K Sell
1,236
-6,786
-85% -$181K ﹤0.01% 5753
2018
Q4
$189K Sell
8,022
-971
-11% -$26.5K ﹤0.01% 4993
2018
Q3
$348K Buy
8,993
+610
+7% +$22K ﹤0.01% 4656
2018
Q2
$280K Sell
8,383
-6,502
-44% -$231K ﹤0.01% 4730
2018
Q1
$539K Sell
14,885
-6,578
-31% -$228K ﹤0.01% 4151
2017
Q4
$683K Sell
21,463
-2,120
-9% -$72.6K ﹤0.01% 4067
2017
Q3
$882K Buy
23,583
+788
+3% +$26.8K ﹤0.01% 3810
2017
Q2
$712K Buy
22,795
+16,906
+287% +$488K ﹤0.01% 3867
2017
Q1
$145K Sell
5,889
-1,858
-24% -$43.6K ﹤0.01% 4849
2016
Q4
$196K Buy
7,747
+3,866
+100% +$85.8K ﹤0.01% 4802
2016
Q3
$77K Sell
3,881
-325
-8% -$5.68K ﹤0.01% 5163
2016
Q2
$60K Buy
4,206
+325
+8% +$4.97K ﹤0.01% 5381
2016
Q1
$60K Buy
3,881
+1,000
+35% +$14.3K ﹤0.01% 5355
2015
Q4
$50K Sell
2,881
-2,168
-43% -$31.4K ﹤0.01% 5813
2015
Q3
$61K Buy
5,049
+2,168
+75% +$27.8K ﹤0.01% 5649
2015
Q2
$35K Sell
2,881
-25
-0.9% -$246 ﹤0.01% 6335
2015
Q1
$24K Buy
2,906
+25
+0.9% +$196 ﹤0.01% 6793
2014
Q4
$22K Buy
+2,881
New +$20.6K ﹤0.01% 7517

Other funds holding LMAT